Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01181960 · ClinicalTrials.gov registry record
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
A clinical trial, sponsored by Janssen Scientific Affairs.
- Completed
- Registry status
- 1,066
- Enrollment target
NCT01181960: Completed study, sponsored by Janssen Scientific Affairs.
NCT01181960 is a clinical trial that has completed, run by Janssen Scientific Affairs. The registered enrollment target is 1,066 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01181960 has completed, sponsored by Janssen Scientific Affairs.
- COMPLETED
- Registry status
- 1,066 participants
- Enrollment target
Study Summary
The purpose of this study is to build a data repository that can be used to understand pharmaceutical utilization patterns among patients being treated in community behavioral health organizations (CBHOs) for schizophrenia or bipolar I disorder.
Interventions
- DRUG Risperidone long acting injectable - New Starts
- DRUG Risperidone long acting injectable - Continuous Users
- DRUG Paliperidone Palmitate -New and Continuous Users
- DRUG Other Antipsychotics - New Starts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,066 participants |
| Start Date | 2010-08 |
| Est. Completion | 2013-11 |
What the finished NCT01181960 record still lists
NCT01181960 is an observational study that tracks outcomes without assigning an intervention. Its 1,066 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 4 interventions - of which Risperidone long acting injectable - New Starts is the first listed.
NCT01181960 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01181960 about?
NCT01181960 is a clinical study titled "Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations". The purpose of this study is to build a data repository that can be used to understand pharmaceutical utilization patterns among patients being treated in community behavioral health organizations (CBHOs) for schizophrenia or bipolar I disorder.
What is the current status of trial NCT01181960?
This trial is currently completed. The enrollment target is 1,066 participants. The study started on 2010-08. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01181960?
The interventions under investigation include: Risperidone long acting injectable - New Starts (DRUG), Risperidone long acting injectable - Continuous Users (DRUG), Paliperidone Palmitate -New and Continuous Users (DRUG), Other Antipsychotics - New Starts (DRUG).
Who is sponsoring clinical trial NCT01181960?
This trial is sponsored by Janssen Scientific Affairs, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04165798 · 1,065 participants
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- NCT06751043 · 1,072 participants · NA
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
- NCT05520762 · 1,060 participants · NA
Hospital Airway Resuscitation Trial
- NCT05911568 · 1,060 participants
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia